The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,804.50
Bid: 1,804.50
Ask: 1,805.00
Change: -5.50 (-0.30%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,811.00
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Vouchers, Grocers, Boohoo

Sun, 05th Jul 2020 15:59

(Sharecast News) - Radical plans to give all adults £500 and children £250 in vouchers to spend in sectors of the economy worst hit by the Covid-19 crisis are being considered by the Treasury. The proposals, drawn up by the Resolution Foundation think tank, which has had recent talks with the Treasury about its ideas, are aimed at kickstarting economic recovery by triggering a highly targeted surge in spending. Under the plans the vouchers could only be spent in certain sectors, such as hospitality and "face to face" retail, as opposed to online. - Guardian

Britain's grocers are gearing up for a massive price war amidst fears unemployment could rise above four million. More than 14,000 jobs were lost this week as a coronavirus jobs bloodbath hit the economy. The jobs cull has left supermarket bosses scrambling to show they are competitive on price as household budgets are squeezed due to the crisis. They are worried that the German discounters Aldi and Lidl will repeat the sort of market-share gains made after the 2008 financial crash. - Mail on Sunday

Workers in Leicester making clothes destined for the fashion giant Boohoo are being paid as little as £3.50 an hour, an undercover Sunday Times investigation has found. [...] The undercover reporter spent two days working in the factory where he was told to expect £3.50 an hour, despite the minimum wage in Britain for those aged 25 and over being £8.72. He obtained covert video footage of himself packing garments made in the factory under the label of Nasty Gal, which is owned by the fast-fashion brand Boohoo whose boss, Mahmud Kamani, is set to scoop a £50m bonus. - Sunday Times

Employers planning mass redundancies of furloughed workers face restrictions that may force them to pay back months of wages to the taxpayer. The Treasury has panicked some businesses by rewording the purpose of the Coronavirus Job Retention Scheme to say it is "integral" that its money is "used by the employer to continue the employment of employees". The change, unveiled last week, has meanwhile sparked hopes among 
 campaigners that employers will think twice before laying off swathes of Britain's 9.3 million furloughed workforce. - Sunday Telegraph

Glaxo Smith Kline and Sanofi are close to agreeing a £500m deal to supply the British government with 60 million doses of their coronavirus vaccine. The business department is understood to be taking an option to buy the vaccine from the pharmaceuticals giants should it work in human trials, which are due to begin in September. The deal for an as yet unproven vaccine underlines ministers' desperation to secure a supply as countries scramble to buy up possible Covid-19 treatments. - Sunday Times

Rolls-Royce is preparing to close its final salary pension scheme four years early to conserve cash as grounded aircraft pile pressure on its finances. The jet engine maker is seeking to end accrual of future benefits now, rather than in 2024. If Rolls gets the go-ahead from pension members and trustees following a consultation, it is likely to save a total of about £500m in contributions. Under the current arrangements, in the last financial year Rolls made total cash contributions to the pension scheme of more than £150m. - Sunday Telegraph

Bank of England governor Andrew Bailey has written to lenders warning them of the challenges negative interest rates would bring. Bailey, who succeeded Mark Carney as the virus crisis was taking hold in March, said that adapting to an unprecedented move into negative territory, where the Bank would charge commercial lenders to store reserves, would be "a significant operational undertaking for firms". He noted that many would need 12 months to change computer systems, update financial contracts designed for a world of positive interest rates and work out how to communicate with clients. - Sunday Times

The Panelbase survey also shows a commanding lead for the SNP heading into next year's Holyrood elections, with a resounding victory for Nicola Sturgeon likely to heighten calls for a second referendum on independence. Support for Scottish independence stands at 54% according to Panelbase poll for the Sunday Times, with 46% support for the union. It is the second survey in recent weeks to show this level of support among Scots for leaving the UK. - The Scotsman
More News
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.